Yan SD - Search Results

1

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD. Lue LF, et al. Among authors: yan sd. Exp Neurol. 2001 Sep;171(1):29-45. doi: 10.1006/exnr.2001.7732. Exp Neurol. 2001. PMID: 11520119

2

Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures.

Rogers J, Lue LF, Walker DG, Yan SD, Stern D, Strohmeyer R, Kovelowski CJ. Rogers J, et al. Among authors: yan sd. Ernst Schering Res Found Workshop. 2002;(39):25-44. doi: 10.1007/978-3-662-05073-6_3. Ernst Schering Res Found Workshop. 2002. PMID: 12066415 Review. No abstract available.

3

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

Lue LF, Yan SD, Stern DM, Walker DG. Lue LF, et al. Among authors: yan sd. Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. doi: 10.2174/1568007054038210. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15975028 Review.

4

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro.

Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J. Lue LF, et al. Among authors: yan sd. Glia. 2001 Jul;35(1):72-9. doi: 10.1002/glia.1072. Glia. 2001. PMID: 11424194

5

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.

Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX, Yan SS. Fang F, et al. FASEB J. 2010 Apr;24(4):1043-55. doi: 10.1096/fj.09-139634. Epub 2009 Nov 11. FASEB J. 2010. PMID: 19906677 Free PMC article.

6

RAGE: a novel cellular receptor for advanced glycation end products.

Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. Schmidt AM, et al. Among authors: yan sd. Diabetes. 1996 Jul;45 Suppl 3:S77-80. doi: 10.2337/diab.45.3.s77. Diabetes. 1996. PMID: 8674899 Review.

7

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. Yan SD, et al. Nature. 1996 Aug 22;382(6593):685-91. doi: 10.1038/382685a0. Nature. 1996. PMID: 8751438

8

The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.

Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D, Schmidt AM. Hori O, et al. Among authors: yan sd. Nephrol Dial Transplant. 1996;11 Suppl 5:13-6. doi: 10.1093/ndt/11.supp5.13. Nephrol Dial Transplant. 1996. PMID: 9044300 Review.

9

What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.

Yan SD, Stern D, Schmidt AM. Yan SD, et al. Eur J Clin Invest. 1997 Mar;27(3):179-81. doi: 10.1046/j.1365-2362.1996.00072.x. Eur J Clin Invest. 1997. PMID: 9088851 Review. No abstract available.

10

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Schmidt AM, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Among authors: yan sd. Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page